We are able to offer API directly into capsules and vials using micro-dosing technology as well as the more traditional development pathways. The micro-dosing drug in capsule (DIC) and drug in vial (DIV) approach offers time and cost efficiencies as well as the potential to reduce wastage of often expensive APIs.
Following early stage development, we continue with further development, scale-up and process validation ahead of commercial launch for a variety of dosage forms, all supported by full in-house analytical development and release laboratory.
As part of our drug development process we are able to offer formulation development services for a variety of dosage forms including:
- Tablets, capsules and powders
- Gels and creams
- Liquids, solutions, suspensions and emulsions
- Suppositories and pessaries
- Granules for reconstitution
- Drug in capsule/vial